Retour aux projets

25384.1 PFLS-LS

25384.1 PFLS-LS

Résumé

Identification of the most suitable drug candidate(s) of first selective endocannabinoid reuptake inhibitors (SERIs) for clinical development in neuropsychiatric disorders

Textes supplémentaires

Abstract

Selective endocannabinoid reuptake inhibitors (SERIs) are new chemical entities that modulate the endocannabinoid system with a potentially more effective and safer pharmacological profile as compared to other cannabinoid drugs. Preliminary analytical and behavioral pharmacology experiments indicate that SERIs are active in the central nervous system. The aim of this project relates to the identification of the best drug candidate(s) for clinical development and selection of the most suitable target indication(s) among neuropsychiatric disorders.

Participants

Andrea Chicca

Kontaktperson

chicca@ibmm.unibe.ch

Universität Bern Institute of Biochemistry and Molec Andrea Chicca Bühlstrasse 28 3012 Bern BE CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2017-03-31
Date de fin
2019-05-31
Coûts totaux approuvés
CHF 228997.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Industrielle Produktivität und Technologie

Disciplines de recherche

  • T115 Medical technology 100.0%